High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults
Nino Emanuel Landler, Katja Vu Bartholdy, Brian Lee Claggett, Lothar Wiese et al.
Citations
13 citations
Journal
JAMA Cardiology
Topics
Influenza Virus Research Studies
Field-Weighted Citation Impact (FWCI)
17.60
article
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults
Nino Emanuel Landler, Katja Vu Bartholdy, Brian Lee Claggett, Lothar Wiese, Caroline Espersen, Morten Sengeløv, Matthew M. Loiacono, Lise Witten Davodian, Camilla Ikast Ottosen, Kristoffer Grundtvig Skaarup, Adam Cadovius Femerling Langhoff, Lars Køber, Mats Christian Højbjerg Lassen, Gunnar Gislason, Manan Pareek, Jens‐Ulrik Stæhr Jensen, Marine Dufournet, Filip Soeskov Davidovski, Lisa Steen Duus, Carsten Schade Larsen, Anne Bjerg Nielsen, Daniel Modin, Kira Hyldekær Janstrup, Maria Dons, Cyril Jean‐Marie Martel, Rebecca C. Harris, Michael Dalager‐Pedersen, Martin Landray, Niklas Dyrby Johansen, Tor Biering‐Sørensen, Pradeesh Sivapalan, Katrine Feldballe Bernholm, Julie Borchsenius, Frederik Holme Fussing, Anne Jensen, Lykke Larsen, Scott Solomon
article en
13 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA CardiologyVol. 10(11)
Institutions
Statens Serum Institut (DK), University of Copenhagen (DK), Brigham and Women's Hospital (US), Steno Diabetes Centers (DK), Harvard University (US), Aalborg University Hospital (DK), Odense University Hospital (DK), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Morristown Medical Center (US), Rigshospitalet (DK), Sanofi (France) (FR), University of Oxford (GB), Zealand University Hospital (DK), C3I (United States) (US), European Environment Agency (DK), University of Delaware (US)
Funders
Amgen, Pfizer, AstraZeneca, Sanofi, Boston Scientific Corporation, Regeneron Pharmaceuticals, Moderna, Novo Nordisk, Seqirus